4-(6-(1-methyl-1H-indol-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-N-(2,2,2-trifluoroethyl)thiophene-2-carboxamide

ID: ALA4541288

PubChem CID: 155551158

Max Phase: Preclinical

Molecular Formula: C22H16F3N5OS

Molecular Weight: 455.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cn1ccc2ccc(-c3cnc4c(-c5csc(C(=O)NCC(F)(F)F)c5)cnn4c3)cc21

Standard InChI:  InChI=1S/C22H16F3N5OS/c1-29-5-4-13-2-3-14(6-18(13)29)16-8-26-20-17(9-28-30(20)10-16)15-7-19(32-11-15)21(31)27-12-22(23,24)25/h2-11H,12H2,1H3,(H,27,31)

Standard InChI Key:  FJGCZPIXTJBNIZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   18.7005  -10.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7005  -11.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4058  -11.7626    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4058  -10.1282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1110  -10.5409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1110  -11.3591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8892  -11.6121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3702  -10.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8892  -10.2882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1433  -12.3934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6629  -13.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1432  -13.7157    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.9205  -13.4632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9204  -12.6460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5816  -13.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4962  -14.7562    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3281  -13.6111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9893  -14.0915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7358  -13.7591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3969  -14.2394    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.8212  -12.9464    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.4402  -13.3433    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.9940  -10.1365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9929   -9.3182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2848   -8.9118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2910  -10.5467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5824  -10.1439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5784   -9.3252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7985   -9.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3204   -9.7407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8050  -10.4006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5562  -11.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  7 10  1  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 23 24  2  0
 24 25  1  0
 25 28  2  0
 27 26  2  0
 26 23  1  0
  1 23  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 27  1  0
 31 32  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4541288

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 455.47

Molecular Weight (Monoisotopic): 455.1028

AlogP: 4.91

#Rotatable Bonds: 4

Polar Surface Area: 64.22

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.90

CX Basic pKa: 0.98

CX LogP: 4.21

CX LogD: 4.21

Aromatic Rings: 5

Heavy Atoms: 32

QED Weighted: 0.42

Np Likeness Score: -1.81

References

1. Sloman DL, Noucti N, Altman MD, Chen D, Mislak AC, Szewczak A, Hayashi M, Warren L, Dellovade T, Wu Z, Marcus J, Walker D, Su HP, Edavettal SC, Munshi S, Hutton M, Nuthall H, Stanton MG..  (2016)  Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties.,  26  (17): [PMID:27491711] [10.1016/j.bmcl.2016.02.003]

Source

Source(1):

• Scientific Literature